KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,220,000 | -28.0% | 60,000 | -45.5% | 0.89% | -34.7% |
| Q1 2017 | $8,634,000 | +140.7% | 110,000 | +37.5% | 1.37% | +98.7% |
| Q4 2016 | $3,587,000 | -99.9% | 80,000 | -11.1% | 0.69% | -13.8% |
| Q3 2016 | $5,027,400,000 | +143540.0% | 90,000 | +28.6% | 0.80% | +28.3% |
| Q2 2016 | $3,500,000 | +10.3% | 70,000 | +22.8% | 0.62% | +22.9% |
| Q3 2015 | $3,174,000 | -21.1% | 57,000 | -13.6% | 0.51% | +4.8% |
| Q2 2015 | $4,024,000 | +55.0% | 66,000 | +46.7% | 0.48% | +10.3% |
| Q1 2015 | $2,596,000 | +28.6% | 45,000 | +28.6% | 0.44% | -25.1% |
| Q4 2014 | $2,018,000 | – | 35,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $185,086,000 | 58.62% |
| BAINCO INTERNATIONAL INVESTORS | 879,840 | $69,059,000 | 9.77% |
| Coastal Bridge Advisors, LLC | 235,140 | $18,456,000 | 6.29% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,433,899 | $112,547,000 | 5.71% |
| NEXTHERA CAPITAL LP | 105,000 | $8,241,000 | 4.20% |
| ARK Investment Management | 87,364 | $6,857,000 | 1.98% |
| Casdin Capital, LLC | 42,500 | $3,336,000 | 1.97% |
| BB BIOTECH AG | 740,000 | $58,083,000 | 1.90% |
| FT Options LLC | 81,700 | $1,287,000 | 1.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 55,500 | $4,346,000 | 1.66% |